{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:37:52Z","timestamp":1790386672399,"version":"4.1.0"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Buchmann fellowship"},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1300\/13"],"award-info":[{"award-number":["1300\/13"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"TEVA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1093\/hmg\/ddz005","type":"journal-article","created":{"date-parts":[[2019,1,6]],"date-time":"2019-01-06T12:20:51Z","timestamp":1546777251000},"source":"Crossref","is-referenced-by-count":44,"title":["The effect of mutant GBA1 on accumulation and aggregation of \u03b1-synuclein"],"prefix":"10.1093","volume":"28","author":[{"given":"Gali","family":"Maor","sequence":"first","affiliation":[{"name":"School of Molecular Cell Biology and Biotechnology, Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Rapaport","sequence":"additional","affiliation":[{"name":"School of Molecular Cell Biology and Biotechnology, Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Horowitz","sequence":"additional","affiliation":[{"name":"School of Molecular Cell Biology and Biotechnology, Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"key":"2019051613101727100_ref1","first-page":"65","article-title":"Gaucher's disease","volume":"6","author":"Beutler","year":"1980","journal-title":"Compr. Ther."},{"key":"2019051613101727100_ref2","first-page":"703","article-title":"Gaucher disease: a century of delineation and research. Enzyme replacement therapy: model and clinical studies","volume":"95","author":"Beutler","year":"1982","journal-title":"Prog. Clin. Biol. Res."},{"key":"2019051613101727100_ref3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0163-7258(82)90072-9","article-title":"Lysosomal storage diseases","volume":"19","author":"Brady","year":"1982","journal-title":"Pharmacol. Ther."},{"key":"2019051613101727100_ref4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archinte.159.8.881","article-title":"Gaucher disease","volume":"159","author":"Beutler","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"2019051613101727100_ref5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/(SICI)1098-1004(1996)8:3<207::AID-HUMU2>3.0.CO;2-6","article-title":"Glucocerebrosidase (Gaucher disease)","volume":"8","author":"Beutler","year":"1996","journal-title":"Hum. Mutat."},{"key":"2019051613101727100_ref6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum. Mutat."},{"key":"2019051613101727100_ref7","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/mds.23213","article-title":"Functional brain imaging in glucocerebrosidase mutation carriers with and without parkinsonism","volume":"25","author":"Kono","year":"2010","journal-title":"Mov. Disord."},{"key":"2019051613101727100_ref8","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2008.06.037","article-title":"Chemical and biological approaches synergize to ameliorate protein-folding diseases","volume":"134","author":"Mu","year":"2008","journal-title":"Cell"},{"key":"2019051613101727100_ref9","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"2019051613101727100_ref10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1750-1172-8-140","article-title":"Unfolded protein response in Gaucher disease: from human to Drosophila","volume":"8","author":"Maor","year":"2013","journal-title":"Orphanet J. Rare Dis."},{"key":"2019051613101727100_ref11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson's syndrome in type I Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM"},{"key":"2019051613101727100_ref12","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa033277","article-title":"Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews","volume":"351","author":"Aharon-Peretz","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"2019051613101727100_ref13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymgme.2004.11.007","article-title":"Gaucher disease and parkinsonism","volume":"84","author":"Sidransky","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"2019051613101727100_ref14","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"2019051613101727100_ref15","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1212\/WNL.0b013e3181b28601","article-title":"Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset","volume":"73","author":"Sidransky","year":"2009","journal-title":"Neurology"},{"key":"2019051613101727100_ref16","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.0b013e318253d54b","article-title":"Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study","volume":"78","author":"Alcalay","year":"2012","journal-title":"Neurology"},{"key":"2019051613101727100_ref17","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"2019051613101727100_ref18","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing","volume":"69","author":"Cullen","year":"2011","journal-title":"Ann. Neurol."},{"key":"2019051613101727100_ref19","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-010-0741-7","article-title":"Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders","volume":"120","author":"Goker-Alpan","year":"2010","journal-title":"Acta Neuropathol."},{"key":"2019051613101727100_ref20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"2019051613101727100_ref21","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1073\/pnas.1108197108","article-title":"CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy","volume":"108","author":"Sardi","year":"2011","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"2019051613101727100_ref22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1471-4159.2012.07879.x","article-title":"Glucocerebrosidase mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease","volume":"123","author":"Kurzawa-Akanbi","year":"2012","journal-title":"J. Neurochem."},{"key":"2019051613101727100_ref23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ymgme.2011.06.008","article-title":"Aggregation of alpha-synuclein in brain samples from subjects with glucocerebrosidase mutations","volume":"104","author":"Choi","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"2019051613101727100_ref24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13024-015-0010-2","article-title":"Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies","volume":"10","author":"Chiasserini","year":"2015","journal-title":"Mol. Neurodegener."},{"key":"2019051613101727100_ref25","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/brain\/awv179","article-title":"Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations","volume":"138","author":"Alcalay","year":"2015","journal-title":"Brain"},{"key":"2019051613101727100_ref26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann Neurol"},{"key":"2019051613101727100_ref27","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.4161\/auto.29074","article-title":"Glucocerebrosidase deficits in sporadic Parkinson disease","volume":"10","author":"Murphy","year":"2014","journal-title":"Autophagy"},{"key":"2019051613101727100_ref28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/acn3.177","article-title":"Progressive decline of glucocerebrosidase in aging and Parkinson's disease","volume":"2","author":"Rocha","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"2019051613101727100_ref29","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.stemcr.2016.01.013","article-title":"ER stress and autophagic perturbations lead to elevated extracellular alpha-synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons","volume":"6","author":"Fernandes","year":"2016","journal-title":"Stem Cell Reports"},{"key":"2019051613101727100_ref30","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1093\/brain\/awu291","article-title":"Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation","volume":"137","author":"Fishbein","year":"2014","journal-title":"Brain"},{"key":"2019051613101727100_ref31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40478-018-0538-9","article-title":"D409H GBA1 mutation accelerates the progression of pathology in A53T alpha-synuclein transgenic mouse model","volume":"6","author":"Kim","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"2019051613101727100_ref32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2018.1444314","article-title":"Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations","author":"Li","year":"2018","journal-title":"Autophagy"},{"key":"2019051613101727100_ref33","first-page":"2712","article-title":"The contribution of mutant GBA to the development of Parkinson disease in Drosophila","volume":"25","author":"Maor","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"2019051613101727100_ref34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0069147","article-title":"Expression of human Gaucher disease gene GBA generates neurodevelopmental defects and ER stress in Drosophila eye","volume":"8","author":"Suzuki","year":"2013","journal-title":"PLoS One"},{"key":"2019051613101727100_ref35","doi-asserted-by":"crossref","DOI":"10.1038\/srep31380","article-title":"Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models","volume":"6","author":"Sanchez-Martinez","year":"2016","journal-title":"Sci. Rep."},{"key":"2019051613101727100_ref36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0009-3084(97)02658-3","article-title":"Synthesis and mass spectrometric characterization of digoxigenin and biotin labeled ganglioside GM1 and their uptake by and metabolism in cultured cells","volume":"86","author":"Albrecht","year":"1997","journal-title":"Chem. Phys. Lipids"},{"key":"2019051613101727100_ref37","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3892\/mmr.2017.6191","article-title":"The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SHSY5Y cells","volume":"15","author":"Horst","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"2019051613101727100_ref38","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"2019051613101727100_ref39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"2019051613101727100_ref40","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1172\/JCI200215777","article-title":"Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies","volume":"110","author":"Neumann","year":"2002","journal-title":"J. Clin. Invest."},{"key":"2019051613101727100_ref41","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1523\/JNEUROSCI.0285-07.2007","article-title":"Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo","volume":"27","author":"Periquet","year":"2007","journal-title":"J. Neurosci."},{"key":"2019051613101727100_ref42","doi-asserted-by":"crossref","first-page":"35863","DOI":"10.1074\/jbc.M111.253450","article-title":"Effect of Ser-129 phosphorylation on interaction of alpha-synuclein with synaptic and cellular membranes","volume":"286","author":"Visanji","year":"2011","journal-title":"J. Biol. Chem."},{"key":"2019051613101727100_ref43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nbd.2007.01.014","article-title":"Alpha-synuclein and its disease-related mutants interact differentially with the microtubule protein tau and associate with the actin cytoskeleton","volume":"26","author":"Esposito","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"2019051613101727100_ref44","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/bmc.931","article-title":"Proteomics of Caenorhabditis elegans over-expressing human alpha-synuclein analyzed by fluorogenic derivatization-liquid chromatography\/tandem mass spectrometry: identification of actin and several ribosomal proteins as negative markers at early Parkinson's disease stages","volume":"22","author":"Ichibangase","year":"2008","journal-title":"Biomed. Chromatogr."},{"key":"2019051613101727100_ref45","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1021\/pr060488o","article-title":"Protein expression in a Drosophila model of Parkinson's disease","volume":"6","author":"Xun","year":"2007","journal-title":"J. Proteome Res."},{"key":"2019051613101727100_ref46","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuron.2017.11.036","article-title":"Alpha-synuclein induces mitochondrial dysfunction through spectrin and the actin cytoskeleton","volume":"97","author":"Ordonez","year":"2018","journal-title":"Neuron"},{"key":"2019051613101727100_ref47","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1091\/mbc.e08-03-0302","article-title":"{alpha}-synuclein and its A30P mutant affect actin cytoskeletal structure and dynamics","volume":"20","author":"Sousa","year":"2009","journal-title":"Mol. Biol. Cell."},{"key":"2019051613101727100_ref48","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/acel.12359","article-title":"The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration","volume":"14","author":"Deger","year":"2015","journal-title":"Aging Cell"},{"key":"2019051613101727100_ref49","doi-asserted-by":"crossref","DOI":"10.1002\/0471141755.ph1208s25","article-title":"Measurement of cell death in mammalian cells","author":"Cummings","year":"2004","journal-title":"Curr. Protoc. Pharmacol."},{"key":"2019051613101727100_ref50","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/35006074","article-title":"A Drosophila model of Parkinson's disease","volume":"404","author":"Feany","year":"2000","journal-title":"Nature"},{"key":"2019051613101727100_ref51","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/332853a0","article-title":"GAL4 activates transcription in Drosophila","volume":"332","author":"Fischer","year":"1988","journal-title":"Nature"},{"key":"2019051613101727100_ref52","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"key":"2019051613101727100_ref53","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.1520335113","article-title":"Alpha-synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models","volume":"113","author":"Mazzulli","year":"2016","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"2019051613101727100_ref54","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.wnl.0000304039.11891.29","article-title":"Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset","volume":"70","author":"Gan-Or","year":"2008","journal-title":"Neurology"},{"key":"2019051613101727100_ref55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.parkreldis.2018.05.009","article-title":"Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene","volume":"55","author":"Thaler","year":"2018","journal-title":"Parkinsonism Relat. Disord"},{"issue":"Oct 13","key":"2019051613101727100_ref56","article-title":"Neurological effects of GBA mutations","author":"Mullin","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"2019051613101727100_ref57","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1073\/pnas.1220464110","article-title":"Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies","volume":"110","author":"Sardi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2019051613101727100_ref58","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.1616152114","article-title":"Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models","volume":"114","author":"Sardi","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2019051613101727100_ref59","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0014-4800(88)90068-8","article-title":"Macrophages exposed in vitro to conduritol B epoxide resemble Gaucher cells","volume":"48","author":"Newburg","year":"1988","journal-title":"Exp. Mol. Pathol."},{"key":"2019051613101727100_ref60","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/mds.26278","article-title":"No evidence for substrate accumulation in Parkinson brains with GBA mutations","volume":"30","author":"Gegg","year":"2015","journal-title":"Mov. Disord."},{"key":"2019051613101727100_ref61","doi-asserted-by":"crossref","first-page":"13176","DOI":"10.1073\/pnas.1704351114","article-title":"SUMOylation and ubiquitination reciprocally regulate alpha-synuclein degradation and pathological aggregation","volume":"114","author":"Rott","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2019051613101727100_ref62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-6606-2-5","article-title":"Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo","volume":"2","author":"Cullen","year":"2009","journal-title":"Mol. Brain"},{"key":"2019051613101727100_ref63","first-page":"1","article-title":"Relationship between the proteasomal system and autophagy","volume":"4","author":"Lilienbaum","year":"2013","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"2019051613101727100_ref64","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1038\/ncomms5028","article-title":"iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis","volume":"5","author":"Schondorf","year":"2014","journal-title":"Nat. Commun."},{"key":"2019051613101727100_ref65","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/brain\/awt367","article-title":"Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson's disease","volume":"137","author":"Murphy","year":"2014","journal-title":"Brain"},{"key":"2019051613101727100_ref66","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.braindev.2012.12.002","article-title":"Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease","volume":"35","author":"Suzuki","year":"2013","journal-title":"Brain Dev."},{"key":"2019051613101727100_ref67","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/hmg\/ddq292","article-title":"Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease","volume":"19","author":"Ron","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"2019051613101727100_ref68","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/ejn.13654","article-title":"Drosophila mutants lacking octopamine exhibit impairment in aversive olfactory associative learning","volume":"46","author":"Iliadi","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"2019051613101727100_ref69","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fcell.2016.00053","article-title":"ERK1 and ERK2 map kinases: specific roles or functional redundancy?","volume":"4","author":"Busca","year":"2016","journal-title":"Front Cell Dev. Biol."},{"key":"2019051613101727100_ref70","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/neuro.04.005.2009","article-title":"Eight different types of dopaminergic neurons innervate the Drosophila mushroom body neuropil: anatomical and physiological heterogeneity","volume":"3","author":"Mao","year":"2009","journal-title":"Front. Neural. Circuits"}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/28\/11\/1768\/28659085\/ddz005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T17:52:34Z","timestamp":1589997154000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/28\/11\/1768\/5280065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":70,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,1,7]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddz005","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6,1]]},"published":{"date-parts":[[2019,1,7]]},"article-number":"e69147"}}